Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Data Used To Approve Zolgensma Gene Therapy Treatment May Have Been Manipulated: FDA August 7, 2019 Russell Maas Add Your CommentsFederal officials say the pharmaceutical giant, Novartis, intentionally manipulated data collected during animal trials of Zolgensma, a new type of gene therapy for children, but has decided to let it stay on the market.The U.S. Food and Drug Administration (FDA) released a statement this week indicatingย it will allow Zolgensma gene therapy products, intended to treat spinal muscular atrophy in young children, to remain on the market after new evidence indicates the manufacturer intentionally manipulated and withheld inaccurate data readings during its approval process.According to the statement, Novartis only informed the FDA once the spinal muscular atrophy (SMA) gene therapy product was approved for market use.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONZolgensma is a proprietary gene therapy approved by the FDA in May of this year. It is designed to treat pediatric patients less than two years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.The product is designed to address the genetic root cause of SMA by producing a copy of the human SMN gene to halt the progression of the disease through a one-time intravenous protein treatment.Zolgensma is the first therapeutic treatment approved to treat the rare and fatal SMA disease. SMA is a severe neuromuscular disease that causes extreme muscle weakness and paralysis caused by a genetic defect in the SMN1 gene. It is diagnosed in approximately one out of every 10,000 live births and is the leading genetic cause of infant mortality. Generally, if left untreated in children up to 24 months, the disease will require the child to receive permanent ventilation support.On June 28, AveXis and its parent company Novartis, disclosed to the FDA and other health authorities that some of the testing data collected during animal trials was inaccurate, and potentially manipulated before being submitted to the FDA during the approval process.According to the FDA, AveXis was aware of the inaccurate data readings during the time of the approval process and allegedly manipulated the test results before submitting them to the FDA to avoid a delay in approving the treatment for commercial use.AveXis stated that the data in question involves a small portion of the overall submission to the FDA and does not jeopardize the safety, efficacy or quality of Zolgensma use on humans.FDA officials have announced Zolgensma will be permitted to remain on the market, indicating the importance of the treatment to provide potentially life-saving benefits for fragile children outweighs the risk.However, officials have announced they are investigating and assessing the data manipulation during product testing to determine the implications for the FDAโs scientific review. At this time, the investigation is still ongoing and the agency stated a full evaluation of the events is required to see if further actions including civil and criminal penalties should be taken.AveXis Biotechnology Company was acquired by Novartis in 2018. The SMA disease treatments are currently the most expensive medication in the world, costing over $2 million per treatment.Although the FDA is continuing to allow Novartis and sub-company AveXis to remain marketing and selling Zolgensma, the company witnessed a 2.8% drop in stock market shares Tuesday, while competing biotech companies Biogen and Ionis pharmaceuticals, who make revival treatments for SMA seen stock market shares jump 2.1% and 3.3% Written by: Russell MaasManaging Editor & Senior Legal JournalistRussell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโs leading personal injury law firms and oversees the siteโs editorial strategy, including SEO and content development. Tags: Children, Clinical Trials, Gene Therapy, Novartis, ZolgensmaMore Lawsuit Stories DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers November 17, 2026 Lawsuit Alleges Dupixent Eczema Treatment Triggered Cutaneous T-Cell Lymphoma November 17, 2026 Filshie Clip Birth Control Lawsuits Cleared for Trial After Judge Rejects CooperSurgical Defense November 17, 2026 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: today)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026) Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: yesterday)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026) Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 4 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers November 17, 2026
Filshie Clip Birth Control Lawsuits Cleared for Trial After Judge Rejects CooperSurgical Defense November 17, 2026
DraftKings Class Action Lawsuit Alleges Sports Betting Odds Changes Misled Consumers (Posted: today)A class action lawsuit alleges DraftKings makes changes to its wagering format that are intentionally designed to trick consumers into placing bets they did not intend to make.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITOnline Gambling Class Action Claims Betsperts Used Aggressive Marketing Tactics to Keep Players Spending (11/13/2026)DraftKings, FanDuel Face Questions From Lawmakers Over VIP Rewards Targeting Problem Gamblers (11/02/2026)DraftKings Gambling Lawsuit Alleges Illegal Scheme Fueled Addiction (10/27/2026)
Nitrous Oxide Injury Lawsuit Targets Amazon, Online Retailers for Illegal Drug Sales (Posted: yesterday)About 100 different plaintiffs have filed a lawsuit alleging Amazon served as the storefront for multiple illicit nitrous oxide dealers, leading to severe injuries and addiction.MORE ABOUT: NITROUS OXIDE LAWSUITNitrous Oxide Paralysis Lawsuit Filed Against Galaxy Gas (11/04/2026)Dozens File Joint Nitrous Oxide Addiction Lawsuit Against Amazon, Third-Party Retailers (10/15/2026)Nitrous Oxide Injury Lawsuit Filed Over B12 Deficiency, Long-Term Side Effects (10/09/2026)
Pesticide Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (Posted: 4 days ago)A man’s lawsuit blames pesticides for his development of Parkinson’s disease after living near nurseries in California for nearly 20 years.MORE ABOUT: CHLORPYRIFOS PARKINSONโS DISEASE LAWSUITChlorpyrifos Pesticide Exposure Detected in Infants, Raising New Neurotoxicity Concerns (11/03/2026)Chlorpyrifos Ban Takes Effect Across EU as Studies Link Pesticide Exposure to Parkinsonโs Disease (10/01/2026)Parkinson’s Disease Lawsuit Filed Against Chlorpyrifos Manufacturers (09/23/2026)